Moderate

Perioperative management of the dialysis patient

Perioperative assessment · Perioperative & Anaesthesia
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

End-stage renal disease patients on dialysis have altered fluid, electrolyte and drug handling, high cardiovascular risk, anaemia, platelet dysfunction and a precious vascular access to protect. Timing surgery around dialysis and managing potassium are central to safe perioperative care.

Red flags

  • Potassium >6.0 mmol/L or ECG changes of hyperkalaemia
  • Pulmonary oedema from fluid overload
  • Significant perioperative bleeding (uraemic platelet dysfunction)
  • Signs of myocardial ischaemia or new arrhythmia
  • Compromise of the dialysis access

Assessment

Differential diagnosis

  • Hyperkalaemia (missed/inadequate dialysis, tissue breakdown)
  • Fluid overload / pulmonary oedema versus hypovolaemia post-dialysis
  • Uraemic platelet dysfunction causing bleeding
  • Cardiac disease (ischaemia, LVH, pericardial effusion)
  • Metabolic acidosis

Investigations

  • Urea and electrolytes including potassium immediately before surgery (and after dialysis)
  • FBC (anaemia, platelets) and coagulation; group and save (bleeding risk)
  • ECG for hyperkalaemia and ischaemia; consider echocardiography if indicated
  • Fluid status assessment (weight relative to dry weight, examination)
  • Venous/arterial blood gas for acid-base and potassium

Management

  • Plan surgery ideally the day after dialysis (euvolaemic, non-heparinised, normal potassium), not immediately after (residual heparin, relative hypovolaemia)
  • Check and correct potassium before induction; treat hyperkalaemia if present
  • Protect the arteriovenous fistula: no blood pressure cuff, cannula or venepuncture in that limb; pad and document a palpable thrill
  • Optimise fluid balance carefully — avoid overload while maintaining perfusion; use dextrose/balanced fluids judiciously and avoid potassium-containing fluids in hyperkalaemia
  • Adjust drug choices for renal clearance (avoid accumulating agents and nephrotoxins); prefer atracurium/cisatracurium for neuromuscular blockade
  • Maintain cardiovascular stability given high ischaemic risk and consider invasive monitoring for major surgery
  • Address uraemic bleeding tendency if excessive oozing (consider desmopressin)
  • Plan postoperative dialysis timing and monitor potassium and fluid status

Drugs & doses

Hyperkalaemia — Calcium gluconate 10% 10 mL IV (cardioprotection) plus Insulin 10 units in 25 g glucose IV and Salbutamol 10-20 mg nebulised
Neuromuscular blockade — Atracurium 0.5 mg/kg IV (organ-independent elimination)
Uraemic bleeding — Desmopressin 0.3 microgram/kg IV
Avoid potassium-containing fluids and nephrotoxic NSAIDs; use balanced crystalloid cautiously

Disposition

Stable patients recover on the ward with electrolyte monitoring and planned postoperative dialysis; hyperkalaemia, overload or instability warrants critical-care/renal input.

Complications & pitfalls

  • Hyperkalaemic cardiac arrest
  • Fluid overload or hypotension from fluid mismanagement
  • Bleeding from uraemic platelet dysfunction
  • Loss of vascular access
  • Cardiac ischaemia/arrhythmia

Exam pearls

  • Operate the day after, not the day of, dialysis — fresh dialysis leaves residual heparin and relative hypovolaemia
  • Always check potassium before induction and treat hyperkalaemia proactively
  • The fistula is the patient's lifeline — no cuffs, cannulae or venepuncture in that arm, and document the thrill
  • Use renally safe drugs (atracurium/cisatracurium; avoid long-acting opioids accumulating as morphine-6-glucuronide)
  • Suxamethonium is acceptable if potassium is normal, but avoid it with pre-existing hyperkalaemia

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.